Back
CRISPR Therapeutics AG Stock Price Chart
Sponsored
CRSP
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$41.93
Seasonality Move:
9.15%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.62 | Buy |
20-day SMA: | 43.21 | Sell |
50-day SMA: | 47.05 | Sell |
200-day SMA: | 52.45 | Sell |
8-day EMA: | 41.19 | Buy |
20-day EMA: | 42.91 | Sell |
50-day EMA: | 45.58 | Sell |
200-day EMA: | 51.28 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.04 | Sell |
Relative Strength Index (14 RSI): | 45.56 | Sell |
Chaikin Money Flow: | -481565 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.09 - 49.71) | Sell |
Bollinger Bands (100): | (43.88 - 50.34) | Sell |
CRISPR Therapeutics AG Technical Analysis
Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 42.43 while CRSP 8-day simple moving average is 40.62, which is a Buy signal.
-
The stock price of CRSP is 42.43 while CRISPR Therapeutics AG 20-day SMA is 43.21, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 47.05 while CRSP share price is 42.43, making it a Sell technically.
-
CRSP stock price is 42.43 and CRISPR Therapeutics AG 200-day simple moving average is 52.45, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $42.43. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.6B
Price in USD:
42.43
Share Volume:
2.3M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
38.20
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 42.43 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 42.43 while CRSP 8-day exponential moving average is 41.19, which is a Buy signal.
-
The stock price of CRSP is 42.43 while CRISPR Therapeutics AG 20-day EMA is 42.91, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 45.58 while CRSP share price is 42.43, making it a Sell technically.
-
CRSP stock price is 42.43 and CRISPR Therapeutics AG 200-day simple moving average is 51.28, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $2.19 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -2.04, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 45.56, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (40.09 - 49.71), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (43.88 - 50.34), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.